ArticleBio-protocol2025
Optimized Secretome Sample Preparation From High Volume Cell Culture Media for LC-MS/MS Proteomic Analysis.
Article in Bio-protocol, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Automated Microvolume Secretome Proteomics Enables Sensitive and Deep Profiling and Noninvasive Single-Embryo Analysis.Journal of proteome research · 2026Article
- Secreted molecules as modulators of somatic embryogenesis efficiency - an overview.Frontiers in plant science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cellular secretome is a rich source of biomarkers and extracellular signaling molecules, but proteomic profiling remains challenging, especially when processing culture volumes greater than 5 mL. Low protein abundance, high serum contamination, and sample loss during preparation limit reproducibility and sensitivity in mass spectrometry-based workflows. Here, we present an optimized and scalable protocol that integrates (i) 50 kDa molecular weight cutoff ultrafiltration, (ii) spin column depletion of abundant serum proteins, and (iii) acetone/TCA precipitation for protein recovery. This workflow enables balanced recovery of both low- and high-molecular-weight proteins while reducing background from serum albumin, thereby improving sensitivity, reproducibility, and dynamic range for LC-MS/MS analysis. Validated in human mesenchymal stromal cell cultures, the protocol is broadly applicable across diverse cell types and experimental designs, making it well-suited for biomarker discovery and extracellular proteomics. Key features • Enables efficient concentration and cleanup of ≥5-500 mL of conditioned media, suitable for low-abundance secreted protein recovery. • Combines 50 kDa ultrafiltration, optional HSA/IgG depletion, and acetone/TCA precipitation for robust removal of serum contaminants and improved signal-to-noise. • Adaptable to various mammalian cell types and serum-free or serum-containing media; scalable for adherent and suspension cultures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.